Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Ghose, R. P.
space
  arrow  Bravo, E. L.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Medical Management of Aldosterone-Producing Adenomas

right arrow Ranjan P. Ghose, MD; Phillip M. Hall, MD; and Emmanuel L. Bravo, MD

20 July 1999 | Volume 131 Issue 2 | Pages 105-108

Background: No data are available on the long-term medical management of aldosterone-producing adenomas.

Objective: To demonstrate the efficacy of medical management of aldosterone-producing adenomas in terms of blood pressure and serum potassium concentration and to discuss morbidity associated with medical management.

Design: Retrospective cohort study.

Setting: Large tertiary care referral center.

Patients: 24 patients with documented aldosterone-producing adenomas who were treated medically for at least 5 years.

Measurements: Aldosterone excretion rate, plasma renin activity, and size and location of adenomas (by computed tomography). Blood pressure and serum electrolytes were measured at the time of diagnosis and last follow-up.

Results: From the time of diagnosis to the time of last follow-up, systolic blood pressure decreased from 175 mm Hg to 129 mm Hg (95% CI for difference, 37.1 to 53.8 mm Hg) and diastolic blood pressure decreased from 106 mm Hg to 79 mm Hg (CI for difference, 20.8 to 33.9 mm Hg). Serum potassium concentration increased from 3.0 mmol/L to 4.3 mmol/L (CI for difference, 1.1 to 1.5 mmol/L).

Conclusions: Medical management of aldosterone-producing adenomas is a viable option for controlling blood pressure and serum potassium concentration.

Author and Article Information
space

From Cleveland Clinic Foundation, Cleveland, Ohio.

Acknowledgments: The authors thank Henry Rolin for statistical analysis and Sandra Stevens for manuscript assistance.

Requests for Reprints: Phillip M. Hall, MD, Department of Nephrology and Hypertension, Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk A101, Cleveland, Ohio 44195; e-mail, hallpm{at}ccf.org.

Current Author Addresses: Drs. Ghose, Hall, and Bravo: Department of Nephrology and Hypertension, Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk A101, Cleveland, Ohio 44195.


Related articles in Annals:

Letters
Medical Management of Aldosterone-Producing Adenomas
J.B. Ferriss
Annals 2000 132: 593-594. [Full Text]  

Letters
Medical Management of Aldosterone-Producing Adenomas
Nor N. Chan
Annals 2000 132: 594. [Full Text]  



This article has been cited by other articles:


Home page
Diabetes CareHome page
D. Smiley and G. Umpierrez
Primary Aldosteronism in Diabetic Subjects With Resistant Hypertension: Response to Ng et al.
Diabetes Care, January 1, 2008; 31(1): e3 - e3.
[Full Text] [PDF]


Home page
Arch SurgHome page
F. E. Nwariaku, B. S. Miller, R. Auchus, S. Holt, L. Watumull, B. Dolmatch, S. Nesbitt, W. Vongpatanasin, R. Victor, F. Wians, et al.
Primary Hyperaldosteronism: Effect of Adrenal Vein Sampling on Surgical Outcome
Arch Surg, May 1, 2006; 141(5): 497 - 503.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. H. Hamrahian, A. G. Ioachimescu, E. M. Remer, G. Motta-Ramirez, H. Bogabathina, H. S. Levin, S. Reddy, I. S. Gill, A. Siperstein, and E. L. Bravo
Clinical Utility of Noncontrast Computed Tomography Attenuation Value (Hounsfield Units) to Differentiate Adrenal Adenomas/Hyperplasias from Nonadenomas: Cleveland Clinic Experience
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 871 - 877.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. L. Phillips, M. M. Walther, J. C. Pezzullo, W. Rayford, P. L. Choyke, A. A. Berman, W. M. Linehan, J. L. Doppman, and J. R. Gill Jr.
Predictive Value of Preoperative Tests in Discriminating Bilateral Adrenal Hyperplasia from an Aldosterone-Producing Adrenal Adenoma
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4526 - 4533.
[Abstract] [Full Text]


Home page
ANN INTERN MEDHome page
N. N. Chan
Medical Management of Aldosterone-Producing Adenomas
Ann Intern Med, April 4, 2000; 132(7): 594 - 594.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J.B. Ferriss
Medical Management of Aldosterone-Producing Adenomas
Ann Intern Med, April 4, 2000; 132(7): 593 - 594.
[Full Text] [PDF]


Home page
JWatch GeneralHome page
Aldosterone-Producing Adenomas Can Be Managed Medically
Journal Watch (General), August 10, 1999; 1999(810): 4 - 4.
[Full Text]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1999 by the American College of Physicians.